Clinical Trial Update: Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose versus standard-dose influenza vaccine in patients with inflammatory bowel disease has been completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Inflammatory Bowel Disease (IBD) | Phase 4 | Status: COMPLETED | Results posted: 2019-09-13